glp-1 medications and anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement Anesthetic Considerations for Patients Taking

We collected fecal samples, extracted bacterial DNA, quantified the absolute levels of bacterial DNA, and sequenced the V3-V4 regions of 16S ribosomal RNA (16S rRNA)

Visceral adipose tissue, the metabolically active fat surrounding internal organs, responds differently to cagrilintide than subcutaneous fat

The most common manifestation is a maculopapular rash appearing 714 days after starting treatment, though immediate hypersensitivity reactions (urticaria, angioedema, anaphylaxis) can occur within hours

While these medications are also available in pill form, the majority of FDA-approved GLP-1 treatments are delivered via injection